ProShares Ultra Nasdaq Biotechnology (BIB) Fell -7.97% or -4.23 To Price $48.82 On Wednesday


ProShares Ultra Nasdaq Biotechnology (BIB) fell -7.97% or -4.23 to $48.82. It is approximately 632330 shares traded, which is 420.28% compare to the average total volume 150455. The market cap of BIB is $209.93 million. The year to date change is 15.4%. The 52 week price range is from $36.05 to $70.82. Price of BIB have changed -7.66% during last week. It have changed -8.53% over last month, -1.30% over last 3 months, -6.22% over last 6 months and -565.18% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BIB is 55.34. It is 13.36% above current price. The 200-day Moving Averages for BIB is 57.22. It is 17.21% above current price. The 52-week High is 70.82. It is 45.06% from the current price. The 52-week Low is 36.05. It is -26.16% from current price.

There are some statistics of BIB. It is has market cap $209.93 million. The share outstanding is 4.30 million. The average volume is 150455. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BIB is 12.67%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BIB is -2.00%.


Tags:

Share this post